<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Doxycycline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00254</strong>&#160; (APRD00597)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>A synthetic tetracycline derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (malaria, falciparum). [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00254/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00254/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00254">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>6-alpha-deoxy-5-oxytetracycline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>6&#945;-deoxy-5-oxytetracycline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Doxycycline hyclate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000896/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000896/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000896">DBSALT000896</a></td>
      </tr>
      <tr>
        <td>
          <strong>Doxycycline hydrochloride</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000897/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000897/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000897">DBSALT000897</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Adoxa</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Alodox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Atridox</td><td>Atrix</td></tr><tr><td>Doryx</td><td>Mayne</td></tr><tr><td>Doxy</td><td>Galpharma</td></tr><tr><td>Doxycin</td><td>Laboratoire Riva</td></tr><tr><td>Doxylin</td><td>Actavis</td></tr><tr><td>Jenacyclin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Microdox</td><td>Micro Labs</td></tr><tr><td>Monodox</td><td>Watson</td></tr><tr><td>Morgidox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>NicAzelDoxyKit</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nu-Doxycycline</td><td>Nu-Pharm</td></tr><tr><td>Ocudox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Oracea</td><td>Galderma</td></tr><tr><td>Periostat</td><td>Alliance</td></tr><tr><td>Supracyclin</td><td>Gr&#252;nenthal</td></tr><tr><td>Vibra-Tabs</td><td>Pfizer</td></tr><tr><td>Vibramycin</td><td>Pfizer</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-bacterial-agents">Anti-Bacterial Agents</a></li>
<li><a href="/mesh/antimalarials">Antimalarials</a></li>
<li><a href="/mesh/tetracyclines">Tetracyclines</a></li></ul></td></tr><tr><th>CAS number</th><td>564-25-0</td></tr><tr><th>Weight</th><td>Average: 444.4346<br>Monoisotopic: 444.153265754</td></tr><tr><th>Chemical Formula</th><td>C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub></td></tr><tr><th>InChI Key</th><td>JBIWCJUYHHGXTC-AKNGSSGZSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[H][C@@]12[C@@H](C)C3=C(C(O)=CC=C3)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Benzenoids</td></tr><tr><th>Class</th><td>Acenes and Derivatives</td></tr><tr><th>Subclass</th><td>Naphthacenes</td></tr><tr><th>Direct parent</th><td>Naphthacenes</td></tr><tr><th>Alternative parents</th><td>Anthracenecarboxylic Acids and Derivatives; Anthraquinones; Tetralins; Phenols and Derivatives; Tertiary Alcohols; Polyols; Primary Carboxylic Acid Amides; Secondary Alcohols; Tertiary Amines; Ketones; Enolates; Carboxylic Acids; Enols; Polyamines</td></tr><tr><th>Substituents</th><td>anthraquinone; tetralin; phenol derivative; benzene; tertiary alcohol; polyol; tertiary amine; carboxamide group; ketone; primary carboxylic acid amide; secondary alcohol; polyamine; enol; carboxylic acid derivative; enolate; carboxylic acid; amine; alcohol; carbonyl group; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the naphthacenes. These are compounds containing a naphthacene moiety, which is a polyaromatic hydrocarbon made of four linearly fused benzene rings.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Doxycycline is indicated for use in respiratory tract infections caused by Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Legionella spp., or Klebsiella spp. It is also used for prophylaxis of malaria. Doxycycline is indicated for a variety of bacterial infections, from Mycobacterium fortuitum and M. marinum, to susceptible E. coli and Brucella spp. It can be used as an alternative to treating plague, tetanus, Campylobacter fetus 
</td></tr><tr><th>Pharmacodynamics</th><td>Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.</td></tr><tr><th>Mechanism of action</th><td>Doxycycline, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Doxycycline reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis. Doxycycline prevents the normal function of the apicoplast of Plasmodium falciparum, a malaria causing organism. </td></tr><tr><th>Absorption</th><td>Completely absorbed following oral administration.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>&gt;90%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic</p></td></tr><tr><th>Route of elimination</th><td>They are concentrated by the liver in the bile and excreted in the urine and feces at high concentrations in a biologically active form.</td></tr><tr><th>Half life</th><td>18-22 hours</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Symptoms of overdose include anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region, skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD<sub>50</sub>=262 mg/kg (I.P. in rat).</td></tr><tr><th>Affected organisms</th><td><ul><li>Enteric bacteria and other eubacteria</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Doxycycline Action Pathway</td><td>Drug action</td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.85</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9881</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.8706</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.699</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8038</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8628</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9562</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8008</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.6551</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9045</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9144</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9293</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9099</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8567</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8086</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9132
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8632
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9941
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.3159 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9946
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7466
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Mylan pharmaceuticals inc</li>
<li>Par pharmaceutical inc</li>
<li>Ranbaxy laboratories ltd</li>
<li>Sandoz inc</li>
<li>Watson laboratories inc</li>
<li>Watson pharmaceuticals inc</li>
<li>Galderma laboratories lp</li>
<li>Rachelle laboratories inc</li>
<li>Ivax pharmaceuticals inc sub teva pharmaceuticals usa</li>
<li>Pfizer laboratories div pfizer inc</li>
<li>Lannett holdings inc</li>
<li>Mutual pharmaceutical co inc</li>
<li>Pliva inc</li>
<li>Mayne pharma international faulding pharm</li>
<li>Warner chilcott bermuda ltd</li>
<li>Medicis pharmaceutical corp</li>
<li>Halsey drug co inc</li>
<li>Heather drug co inc</li>
<li>Interpharm inc</li>
<li>Private formulations inc</li>
<li>Ranbaxy pharmaceuticals inc</li>
<li>Superpharm corp</li>
<li>Warner chilcott div warner lambert co</li>
<li>West ward pharmaceutical corp</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Collagenex inc</li>
<li>App pharmaceuticals llc</li>
<li>Baxter healthcare corp anesthesia and critical care</li>
<li>Bedford laboratories div ben venue laboratories inc</li>
<li>Tolmar inc</li>
<li>Corepharma llc</li>
<li>Larken laboratories inc</li>
<li>Mutual pharmacal co</li>
<li>Truxton inc</li>
<li>Vintage pharmaceuticals inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.actavis.com">Actavis Group</a></li>
<li><a href="http://www.acurapharm.com">Acura Pharmaceutical Technologies Inc.</a></li>
<li>Advanced Pharmaceutical Services Inc.</li>
<li>Advanced Vision Research</li>
<li><a href="http://www.aidarex.com">Aidarex Pharmacuticals LLC</a></li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.amneal.com">Amneal Pharmaceuticals</a></li>
<li><a href="http://www.apacepak.com">Apace Packaging</a></li>
<li><a href="http://www.apicalrx.com">Apical Pharmaceutical Corporation</a></li>
<li>Apotheca Inc.</li>
<li><a href="http://www.apothecon.nl">Apothecon</a></li>
<li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li><a href="http://www.aquapharm.com">Aqua Pharmaceuticals</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.avidaspharma.com">Avidas Pharmaceuticals</a></li>
<li><a href="http://www.bedfordlabs.com">Bedford Labs</a></li>
<li>Belgomex Sprl</li>
<li><a href="http://www.benvenue.com">Ben Venue Laboratories Inc.</a></li>
<li>Bioglan Pharmaceuticals Co.</li>
<li><a href="http://www.bpipack.com">Blenheim Pharmacal</a></li>
<li>Block Drug Corp.</li>
<li><a href="http://www.blurx.us">Blu Pharmaceuticals LLC</a></li>
<li><a href="http://bryantranchprepack.com">Bryant Ranch Prepack</a></li>
<li>Bv Pharbita</li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>Carlisle Laboratories Inc.</li>
<li><a href="http://www.catalent.com">Catalent Pharma Solutions</a></li>
<li>Collagenex Pharmaceuticals Inc.</li>
<li>Community Action Inc. Community Health Services</li>
<li>Comprehensive Consultant Services Inc.</li>
<li><a href="http://www.corepharma.com">Corepharma LLC</a></li>
<li>Coupler Enterprises Inc.</li>
<li><a href="http://www.darbydental.com">Darby Dental Supply Co. Inc.</a></li>
<li>Dept Health Central Pharmacy</li>
<li>DHHS Program Support Center Supply Service Center</li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.dsm.com">DSM Corp.</a></li>
<li>Eon Labs</li>
<li><a href="http://www.galderma.com">Galderma Laboratories</a></li>
<li><a href="http://www.gsms.us">Golden State Medical Supply Inc.</a></li>
<li>Goldline Laboratories Inc.</li>
<li><a href="http://www.hhlabs.com">H and H Laboratories</a></li>
<li><a href="http://hjharkinscompanyinc.com">H.J. Harkins Co. Inc.</a></li>
<li><a href="http://www.hikma.com">Hikma Pharmaceuticals</a></li>
<li><a href="http://www.innoviantpharmacy.com">Innoviant Pharmacy Inc.</a></li>
<li>Ivax Pharmaceuticals</li>
<li>Kaiser Foundation Hospital</li>
<li><a href="http://www.keltman.com">Keltman Pharmaceuticals Inc.</a></li>
<li>Lake Erie Medical and Surgical Supply</li>
<li><a href="http://www.lannett.com">Lannett Co. Inc.</a></li>
<li>Liberty Pharmaceuticals</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.maynepharma.com">Mayne Pharma International Pty Ltd.</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.medvantx.com">Medvantx Inc.</a></li>
<li><a href="http://www.msdh.state.ms.us">Mississippi State Dept Health</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li>Mutual Pharmaceutical Co.</li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li>Oclassen Pharmaceuticals Inc.</li>
<li><a href="http://www.ohmlabs.com">Ohm Laboratories Inc.</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li><a href="http://www.parpharm.com">Par Pharmaceuticals</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li><a href="http://www.patientfirst.com">Patient First Corp.</a></li>
<li>PCA LLC</li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li><a href="http://www.pmrsinc.com">Pharmaceutical Manufacturing Research Services Inc.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pharmaderm.com">Pharmaderm</a></li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.pharmpakinc.com">Pharmpak Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.pliva.com">Pliva Inc.</a></li>
<li><a href="http://www.preferredpharmaceuticals.com">Preferred Pharmaceuticals Inc.</a></li>
<li>Prepackage Specialists</li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.ranbaxy.com">Ranbaxy Laboratories</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li>St Mary's Medical Park Pharmacy</li>
<li><a href="http://statrxusa.exporterus.com">Stat Rx Usa</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.tolmar.com">Tolmar Inc.</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.universal-laboratories.co.uk">Universal Laboratories Inc.</a></li>
<li>Veratex Corp.</li>
<li><a href="http://www.versapharm.com">Versapharm Inc.</a></li>
<li><a href="http://ir.wcrx.com">Warner Chilcott Co. Inc.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li>
<li>WC Pharmaceuticals</li>
<li><a href="http://www.west-ward.com">West-Ward Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Capsule</td><td>Oral</td><td></td></tr><tr><td>Gel, metered</td><td>Periodontal</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of acenocoumarol.</td></tr><tr><td><a href="/drugs/DB00459">Acitretin</a></td><td>Increased risk of intracranial hypertension</td></tr><tr><td><a href="/drugs/DB01370">Aluminium</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>The anticonvulsant, amobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01060">Amoxicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00415">Ampicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>The anticonvulsant, aprobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01574">Attapulgite</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01061">Azlocillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00355">Aztreonam</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01602">Bacampicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01053">Benzylpenicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00307">Bexarotene</a></td><td>Tetracycline derivatives like doxycycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. Due to the risk of developing pseudotumor cerebri (also known as intracranial hypertension), avoid this combination of drugs if possible. If used concomitantly, monitor for evidence of this interaction (eg, dizziness, diplopia, headache).  </td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>The anticonvulsant, butabarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>The anticonvulsant, butalbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>The anticonvulsant, butethal, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01373">Calcium</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00258">Calcium Acetate</a></td><td>Calcium salts such as calcium acetate may decrease the serum concentration of tetracycline derivatives such as doxycycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. </td></tr><tr><td><a href="/drugs/DB01164">Calcium Chloride</a></td><td>Calcium salts such as calcium chloride may decrease the serum concentration of tetracycline derivatives such as doxycycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. </td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>The anticonvulsant, carbamazepine, may decrease the therapeutic effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00578">Carbenicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00766">Clavulanate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01147">Cloxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td>Bile acid sequestrants such as colesevelam may decrease the absorption of Tetracycline Derivatives. Monitor for decreased therapeutic effects of tetracycline derivatives if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. The manufacturer of colesevelam suggests that drugs should be administered at least 1 hour before or 4 hours after colesevelam.</td></tr><tr><td><a href="/drugs/DB01000">Cyclacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00485">Dicloxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01341">Dihydroquinidine barbiturate</a></td><td>The anticonvulsant, dihydroquinidine barbiturate, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>Doxycycline may decrease the contraceptive effect of ethinyl estradiol.</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>The anticonvulsant, ethotoin, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00926">Etretinate</a></td><td>Increased risk of intracranial hypertension</td></tr><tr><td><a href="/drugs/DB00301">Flucloxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>The anticonvulsant, fosphenytoin, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>The anticonvulsant, heptabarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00739">Hetacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>The anticonvulsant, hexobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01592">Iron</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00893">Iron Dextran</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00982">Isotretinoin</a></td><td>Increased risk of intracranial hypertension</td></tr><tr><td><a href="/drugs/DB01378">Magnesium</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01377">Magnesium oxide</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>The anticonvulsant, mephenytoin, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01357">Mestranol</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>The anticonvulsant, methohexital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00563">Methotrexate</a></td><td>The tetracycline, doxycycline, may increase methotrexate toxicity.</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>The anticonvulsant, methylphenobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01603">Meticillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00948">Mezlocillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00607">Nafcillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00713">Oxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00417">Penicillin V</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>The anticonvulsant, pentobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The anticonvulsant, phenobarbital, may decrease the therapeutic effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>The anticonvulsant, phenytoin, may decrease the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00319">Piperacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01604">Pivampicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01605">Pivmecillinam</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The anticonvulsant, primidone, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>The anticonvulsant, quinidine barbiturate, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>The rifamycin decreases the effect of doxycycline</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>The rifamycin decreases the effect of doxycycline</td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>The anticonvulsant , secobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>The anticonvulsant, talbutal, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00706">Tamsulosin</a></td><td>Doxycycline, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Doxycycline is initiated, discontinued, or dose changed.</td></tr><tr><td><a href="/drugs/DB01606">Tazobactam</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00599">Thiopental</a></td><td>Thiopental may decrease the serum levels of Doxycycline. A reduction in antimicrobial effects may occur. An alternative antibiotic may be considered. </td></tr><tr><td><a href="/drugs/DB01607">Ticarcillin</a></td><td>Doxycycline may reduce the effect of Ticarcillin by inhibiting bacterial growth. Ticarcillin exerts its effects on actively growing bacteria. To achieve synergism, Ticarcillin should be administered at least 2 hours prior to using Doxycycline.</td></tr><tr><td><a href="/drugs/DB01036">Tolterodine</a></td><td>Doxycycline may decrease the metabolism and clearance of Tolterodine. Adjust Tolterodine dose and monitor for efficacy and toxicity.</td></tr><tr><td><a href="/drugs/DB00755">Tretinoin</a></td><td>Doxycycline may increase the adverse effects of oral Tretinoin. Increase risk of pseudotumour cerebri. Concurrent therapy should be avoided.</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of warfarin.</td></tr><tr><td><a href="/drugs/DB01593">Zinc</a></td><td>Formation of non-absorbable complexes</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Avoid milk, calcium containing dairy products, iron, antacids, or aluminum salts 2 hours before or 6 hours after using antacids while on this medication.</li>
<li>Take with a full glass of water Do not take calcium, aluminum, magnesium or Iron supplements within 2 hours of taking this medication.</li></ul></td></tr></tbody></table>